combining avelumab and axitinib in advanced renal cell carcinoma (rcc)
Published 7 years ago • 400 plays • Length 2:27Download video MP4
Download video MP3
Similar videos
-
0:44
real-world efficacy of avelumab and axitinib in advanced renal cell carcinoma
-
0:57
avelumab and axitinib for the treatment of advanced rcc
-
1:24
final results of avelumab and axitinib in rcc in the javelin renal 101 trial
-
1:00
pembrolizumab/axitinib and avelumab/axitinib combo for rcc
-
3:30
promising results for axitinib and pembrolizumab in advanced renal cell cancer
-
2:31
axitinib plus pembrolizumab in advanced rcc
-
4:39
avelumab and axitinib vs sunitinib in treating advanced renal cell carcinoma
-
9:23
javelin renal 101: avelumab plus axitinib improve pfs for advanced renal cell cancer
-
1:37
dr. shuch on caveats of avelumab/axitinib combination in rcc
-
9:30
study on avelumab and axitinib vs sunitinib in the treatment of advanced renal cell carcinoma
-
3:41
tide-a: avelumab and intermittent axitinib in metastatic renal cell carcinoma
-
2:32
avelumab plus axitinib improves survival in advanced renal-cell carcinoma patients
-
1:37
immunotherapy combinations improve survival in advanced renal cell carcinoma
-
1:29
phase i/ii study of nivolumab and axitinib for advanced rcc
-
0:47
avelumab plus axitinib shows good efficacy for os and pfs in arcc patients
-
1:06
exciting potential of pembrolizumab combined with axitinib for kidney cancer
-
3:18
exploring the combination of first-line avelumab/axitinib in hcc
-
5:10
real-world treatment outcomes of 1l axitinib pembrolizumab in patients with advanced rcc in the us
-
2:18
pembrolizumab monotherapy and pembro-axitinib for rcc